Ilaris (canakinumab) is a biologic medication that blocks interleukin-1 beta (IL-1β), a protein involved in several inflammatory conditions. At Scottsdale Rheumatology Center, our physicians evaluate patients for Ilaris therapy and provide ongoing care throughout treatment.
Ilaris is prescribed for:
Ilaris is administered periodically based on your specific diagnosis, ranging from as-needed dosing for gout flares to scheduled dosing for periodic fever syndromes. Our physicians determine the appropriate treatment interval and monitor your response over time.
Before starting Ilaris, our physicians review your medical history, including screening for infections such as tuberculosis. Regular monitoring helps our team track your response to therapy. Discuss the full risks and benefits of Ilaris with your physician.
Our office works with most major insurance carriers to support access to Ilaris therapy. Visit our Health Insurance page for more information.
Ilaris is used for gout flares, periodic fever syndromes, and certain forms of arthritis involving excess IL-1 activity.
How often is Ilaris given?Dosing frequency depends on your diagnosis — some patients receive it as needed for flares, while others follow a set schedule.
Is Ilaris a long-term treatment?For chronic conditions, Ilaris may be used long-term under regular physician monitoring.
Book an appointment to discuss Ilaris therapy with Scottsdale Rheumatology Center.
Related: Gout | Infusion Suite
